Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$16.24
-0.06%
Mkt Cap $13.03B
Analyst Ratings
Buy
4
Hold
6
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
Implied Upside
+65.4%
Consensus $26.86 vs current $16.24
NASDAQ·Healthcare·Biotechnology
$16.24
-0.06%
Mkt Cap $13.03B
Buy
4
Hold
6
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
+65.4%
Consensus $26.86 vs current $16.24